-
1.
公开(公告)号:US20070270484A1
公开(公告)日:2007-11-22
申请号:US10573275
申请日:2003-09-25
申请人: Biswajit Das , Mohammad Salman , Sachin Shelke , Atul Hajare , Sanjay Talukdar , Sujata Rathy , Arani Pal , Ashok Rattan
发明人: Biswajit Das , Mohammad Salman , Sachin Shelke , Atul Hajare , Sanjay Talukdar , Sujata Rathy , Arani Pal , Ashok Rattan
IPC分类号: A61K31/7048 , A61P31/04 , C07H17/08
CPC分类号: A61K31/7048 , Y02A50/473
摘要: This invention generally relates to macrolides, more particularly, the invention relates to 3-N-substituted-3-O-substituted erythronolide A derivatives, which are antibacterial agents effective against gram positive or gram negative bacteria and atypical pathogens. The compounds of this invention are more particularly effective against Staphylococcus aureus, Streptococcus pneumoniae, Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa, Haemophilus influenzae. The invention also relates to a process for the preparation of the compounds of the present invention, pharmaceutical compositions containing the compounds of the present invention and the methods for treating bacterial infection.
摘要翻译: 本发明一般涉及大环内酯类,更具体地说,本发明涉及3-N-取代-3-O-取代的红景天苷A衍生物,它们是对革兰氏阳性或革兰氏阴性细菌和非典型病原体有效的抗菌剂。 本发明的化合物对金黄色葡萄球菌,肺炎链球菌,粪肠球菌,大肠杆菌,铜绿假单胞菌,流感嗜血杆菌更为特别有效。 本发明还涉及制备本发明化合物的方法,含有本发明化合物的药物组合物和治疗细菌感染的方法。
-
公开(公告)号:US20090105221A1
公开(公告)日:2009-04-23
申请号:US11576096
申请日:2005-09-28
申请人: Mohammad Salman , Pakala Kumara Savithru Sarma , Arani Pal , Anita Chugh , Suman Gupta , Venkata P. Palle , Naresh Kumar , Kirandeep Kaur
发明人: Mohammad Salman , Pakala Kumara Savithru Sarma , Arani Pal , Anita Chugh , Suman Gupta , Venkata P. Palle , Naresh Kumar , Kirandeep Kaur
IPC分类号: A61K31/55 , C07D223/14 , C07D405/12 , A61P11/00 , A61P1/00
CPC分类号: C07D401/12 , C07D221/24 , C07D405/06 , C07D405/12 , C07D409/12
摘要: This present invention generally relates to muscarinic receptor antagonists of Formula (I), which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the prepration of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.
摘要翻译: 本发明一般涉及式(I)的毒蕈碱受体拮抗剂,其可用于治疗通过毒蕈碱受体介导的呼吸,泌尿和胃肠系统的各种疾病。 本发明还涉及所述化合物的制备方法,包含所公开的化合物的药物组合物,以及通过毒蕈碱受体介导的疾病的治疗方法。
-